243 related articles for article (PubMed ID: 34951111)
1. Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
Fokam J; Mpouel Bala ML; Santoro MM; Takou D; Tala V; Beloumou G; Ngoufack ES; Chenwi C; Pabo Willy Leroi T; Njume D; Teto G; Dambaya B; Djupsa S; Sosso S; Ateba F; Kamta C; Bala L; Njom Nlend AE; Koki Ndombo P; Colizzi V; Perno CF; Ndjolo A
HIV Med; 2022 Jul; 23(6):629-638. PubMed ID: 34951111
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
[TBL] [Abstract][Full Text] [Related]
3. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines.
Fokam J; Takou D; Santoro MM; Akonie HZ; Kouanfack C; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):329-33. PubMed ID: 26602836
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies.
Ka'e AC; Nanfack AJ; Ambada G; Santoro MM; Takou D; Semengue ENJ; Nka AD; Bala MLM; Endougou ON; Elong E; Beloumou G; Djupsa S; Gouissi DH; Fainguem N; Tchouaket MCT; Sosso SM; Kesseng D; Ndongo FA; Sonela N; Kamta ACL; Tchidjou HK; Ndomgue T; Ndiang STM; Nlend AEN; Nkenfou CN; Montesano C; Halle-Ekane GE; Cappelli G; Tiemessen CT; Colizzi V; Ceccherini-Silberstein F; Perno CF; Fokam J
Front Immunol; 2023; 14():1239877. PubMed ID: 37646023
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
Togna Pabo WLR; Fokam J; Njume D; Takou D; Santoro MM; Nyasa RB; Chenwi C; Mpouel ML; Beloumou G; Jagni ESN; Nka AD; Ka'e AC; Teto G; Dambaya B; Djupsa S; Gouissi Anguechia DH; Evariste M; Kamta C; Bala L; Lambo V; Halle-Ekane EG; Colizzi V; Perno CF; Ndjolo A; Ndip Ndip R
PLoS One; 2023; 18(10):e0293326. PubMed ID: 37878637
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
[TBL] [Abstract][Full Text] [Related]
7. Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.
Meriki HD; Tufon KA; Anong DN; Atanga PN; Anyangwe IA; Cho-Ngwa F; Nkuo-Akenji T
PLoS One; 2019; 14(11):e0225575. PubMed ID: 31751428
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
[TBL] [Abstract][Full Text] [Related]
9. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
[TBL] [Abstract][Full Text] [Related]
10. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
[TBL] [Abstract][Full Text] [Related]
11. Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
Fokam J; Takou D; Njume D; Pabo W; Santoro MM; Njom Nlend AE; Beloumou G; Sosso S; Moudourou S; Teto G; Dambaya B; Djupsa S; Tetang Ndiang S; Ateba FN; Billong SC; Kamta C; Bala L; Lambo V; Tala V; Chenwi Ambe C; Mpouel ML; Cappelli G; Cham F; Ndip R; Mbuagbaw L; Koki Ndombo P; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
HIV Med; 2021 Aug; 22(7):567-580. PubMed ID: 33792134
[TBL] [Abstract][Full Text] [Related]
12. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
Takou D; Fokam J; Teto G; Santoro MM; Ceccherini-Silberstein F; Nanfack AJ; Sosso SM; Dambaya B; Salpini R; Billong SC; Gori C; Fokunang CN; Cappelli G; Colizzi V; Perno CF; Ndjolo A
BMC Infect Dis; 2019 Mar; 19(1):246. PubMed ID: 30871487
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings.
Fokam J; Ngoufack Jagni Semengue E; Molimbou E; Etame NK; Santoro MM; Takou D; Mossiang L; Meledie AP; Chenwi CA; Yagai B; Nka AD; Dambaya B; Teto G; Ka'e AC; Beloumou GA; Ndjeyep SCD; Fainguem N; Abba A; Kengni AMN; Tchouaket MCT; Bouba NP; Billong SC; Djubgang R; Saounde ET; Sosso SM; Kouanfack C; Bissek AZ; Eben-Moussi E; Colizzi V; Perno CF; Ceccherini-Silberstein F; Ndjolo A
Microbiol Spectr; 2022 Dec; 10(6):e0342022. PubMed ID: 36259973
[TBL] [Abstract][Full Text] [Related]
15. Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line Treatment.
Kouamou V; Varyani B; Shamu T; Mapangisana T; Chimbetete C; Mudzviti T; Manasa J; Katzenstein D
AIDS Res Hum Retroviruses; 2020 Jul; 36(7):566-573. PubMed ID: 32138527
[TBL] [Abstract][Full Text] [Related]
16. New Aspects of the Virus Life Cycle and Clinical Utility of Next Generation Sequencing based HIV-1 Resistance Testing in the Genomic, the Proviral, and the Viral Reservoir of Peripheral Blood Mononuclear Cells.
Pröll J; Paar C; Taylor N; Skocic M; Freystetter A; Blaimschein A; Mayr R; Niklas N; Atzmüller S; Raml E; Wechselberger C
Curr HIV Res; 2022; 20(3):213-221. PubMed ID: 35331114
[TBL] [Abstract][Full Text] [Related]
17. Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali.
Sylla M; Dolo O; Maiga AI; Traore FT; Coulibaly YA; Togo J; Fofana DB; Dicko-Traore F; Doumbia S; Orsega S; Diallo S; Murphy RL; Calvez V; Marcelin AG
Arch Pediatr; 2019 Jul; 26(5):254-258. PubMed ID: 31307909
[TBL] [Abstract][Full Text] [Related]
18. HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania.
Rugemalila J; Kamori D; Kunambi P; Mizinduko M; Sabasaba A; Masoud S; Msafiri F; Mugusi S; Mutagonda R; Mlunde L; Amani D; Mboya E; Mahiti M; Ruhago G; Mushi J; Sambu V; Mgomella G; Jullu B; Maokola W; Njau P; Mutayoba B; Barabona G; Ueno T; Pembe A; Nagu T; Sunguya B; Aboud S
PLoS One; 2023; 18(2):e0281528. PubMed ID: 36821538
[TBL] [Abstract][Full Text] [Related]
19. Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.
El Annaz H; Recordon-Pinson P; Tagajdid R; Doblali T; Belefquih B; Oumakhir S; Sedrati O; Mrani S; Fleury H
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):944-8. PubMed ID: 21919803
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral resistance following immunological monitoring in a resource-limited setting of western India: A cross-sectional study.
Karade SK; Kulkarni SS; Ghate MV; Patil AA; Londhe R; Salvi SP; Kadam DB; Joshi RK; Rewari BB; Gangakhedkar RR
PLoS One; 2017; 12(8):e0181889. PubMed ID: 28763465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
